Tevogen Bio Company Leadership
| TVGN Stock | 1.18 0.13 9.92% |
Tevogen Bio employs about 12 people. The company is managed by 12 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Tevogen Bio's management performance can provide insight into the firm performance.
Tevogen Bio's Insider Buying Vs Selling
50
Selling | Buying |
Latest Trades
| 2024-10-17 | Neal Flomenberg | Disposed 1078600 @ 1.62 | View | ||
| 2024-06-12 | Kirti Desai | Acquired 3000 @ 0.82 | View |
Monitoring Tevogen Bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Tevogen |
Tevogen Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.8346) % which means that it has lost $0.8346 on every $100 spent on assets. This is way below average. Tevogen Bio's management efficiency ratios could be used to measure how well Tevogen Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -0.0041. In addition to that, Return On Capital Employed is likely to drop to -0.0007. As of the 2nd of December 2024, Total Assets is likely to drop to about 16.2 M. In addition to that, Non Current Assets Total is likely to drop to about 15.8 MAs of the 2nd of December 2024, Common Stock Shares Outstanding is likely to drop to about 148.7 M
Tevogen Bio Workforce Comparison
Tevogen Bio Holdings is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 38,792. Tevogen Bio adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Tevogen Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tevogen Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tevogen Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Tevogen Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Saadi Ryan H. over three months ago Acquisition by Saadi Ryan H. of 2607 shares of Tevogen Bio at 0.7671 subject to Rule 16b-3 | ||
Goh Keow Lin over six months ago Insider Trading | ||
Sadiq Khan over six months ago Acquisition by Sadiq Khan of 969618 shares of Tevogen Bio subject to Rule 16b-3 | ||
Patton Curtis L over six months ago Acquisition by Patton Curtis L of 969618 shares of Tevogen Bio subject to Rule 16b-3 |
Tevogen Bio Notable Stakeholders
A Tevogen Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tevogen Bio often face trade-offs trying to please all of them. Tevogen Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tevogen Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MPH MD | CEO CoFounder | Profile | |
| MD MPH | CEO CoFounder | Profile | |
| Kirti Desai | CFO Director | Profile | |
| Susan MBA | Independent Officer | Profile | |
| Mittul Mehta | Chief Tevogenai | Profile | |
| Sadiq Khan | Chief Officer | Profile | |
| Jeffrey MPH | Member Officer | Profile | |
| Tapan Shah | Head Development | Profile | |
| Kirti CPA | Chief Officer | Profile | |
| Sadiq MBA | Chief Officer | Profile | |
| Neal MD | Global Officer | Profile | |
| Stephen MBA | Chief Officer | Profile |
About Tevogen Bio Management Performance
The success or failure of an entity such as Tevogen Bio Holdings often depends on how effective the management is. Tevogen Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tevogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tevogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 0.10 | 0.09 |
Tevogen Bio Workforce Analysis
Traditionally, organizations such as Tevogen Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tevogen Bio within its industry.Tevogen Bio Manpower Efficiency
Return on Tevogen Bio Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 5.6K | |
| Net Loss Per Executive | 5.6K |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.83) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.